Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome is a research paper published in Cell chemical biology (2023). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Medicines for Malaria Venture
Grant: TDI-4258
Medicines for Malaria Venture
Grant: TDI-8304
National Institute of Allergy and Infectious Diseases
Grant: R01 AI143714
National Institute of Allergy and Infectious Diseases
Grant: R21/R33 AI125781
National Institute of Allergy and Infectious Diseases
Grant: R01 AI109023
National Institute of Allergy and Infectious Diseases
Grant: R21 AI133393
National Institute of Allergy and Infectious Diseases
Grant: R21 AI146387
National Institute of Allergy and Infectious Diseases
Grant: R01 AI158612
US Department of Defense
Grant: W81XWH2210520
US Department of Defense
Grant: W81XWH2210015
Bill & Melinda Gates Foundation
Grant: OPP1162467
Bill & Melinda Gates Foundation
Grant: INV-037899
Medical Research Council
Grant: MC_UP_1201/5
NIAID NIH HHS
Grant: R21 AI127581
NIAID NIH HHS
Grant: R25 AI147376
NIAID NIH HHS
Grant: R33 AI127581
Cornell University
National Institutes of Health
University of Nebraska Medical Center
University of Glasgow
Takeda Pharmaceuticals U.S.A.
MeSH Terms
Keywords